2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
4
Venous Thrombosis
2
Thromboembolism
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Thrombosis
1
Testicular Neoplasms
1
Spinal Stenosis
1
Sezary Syndrome
1
Sarcoma
1
Resected Liver Metastases From Colorectal Cancer
1
Recurrence
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Interventions
Specimen Handling
2
Palliative Care
2
Interviews as Topic
2
Hydromorphone
2
palbociclib
1
neratinib
1
Therapeutics
1
Rehabilitation
1
Referral and Consultation
1
Organizational Objectives
1
Methods
1
Methadone
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Laparotomy
1
Heparin
1
Enoxaparin
1
Educational Status
1
Early Intervention, Educational
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Malignant Female Reproductive System Neoplasm
×
Heparin
×
Clear all
NCT01356329
2016-05-13
Lovenox
National Guard Health Affairs
Phase 3
Suspended
150 enrolled